News

  • Category Legislative News Page 44

    It pays to compare your options, but you need to do this soon, before the Medicare Open Enrollment period ends December 7th. For help shopping for a new drug or health plan locate Medicare benefit counselors in your area. Visit the State Health Insurance Program website — https://www.shiptacenter.org. .A new study by the Journal of the American Medical Association says that the Medicare Part D program could have saved roughly .7 billion in 2017 if doctors and patients had actively opted for generic drugs instead of brand name drugs. .Eighty percent of the nation's active pharmaceutical ingredients come from overseas — and China is its No. 2 supplier, behind only Canada. … Continued

  • Attention Congress

    We want to begin this week's update by reminding you to seriously consider seeing your health care provider if you have been putting it off because of the pandemic. That is especially true if you have a serious health condition and you need treatment or close monitoring. .In a statement, Congressman Doggett said: "Despite groundbreaking medical discoveries, we see no breakthrough in affordability for consumers. Drug pricing in America is a tangled mess, a knot that will take more than one cut to pull apart … Sick patients are tired of seeing Congress do nothing about a problem that affects so many." .The Three Biggest Expenses to Cut In Retirement — Most seniors spend more time clipping coupons to save a few dollars when they do their weekly grocery shopping than they ever spend cutting these three biggies. Spend more time on these and you'll have more money for groceries and everything else. … Continued

The judge's order stops the implementation of the rule until the completion of the notice and comment process. .Is The IRS Paying Illegals Billions In Child Tax Credits? .As we have written recently, Grassley's main problem in getting his bill passed in the Senate is opposition from his fellow Republicans. Grassley said he needs at least 25 Republican co-sponsors to get his bill (S. 2543) to the floor of the Senate for a vote. Ten Republicans other than Grassley have so far made public shows of support for the legislation. .TSCL agrees that lawmakers must take action soon to stabilize the individual health insurance market and to bring down skyrocketing prescription drug prices. In the coming months, our legislative team will continue to monitor and support legislation like the Improving Access to Affordable Prescription Drugs Act (S. 771, H.R. 1776), which would reduce costs and improve care for older Americans. For updates on this bill and others like it, visit the Bill Tracking section of our website or follow TSCL on Twitter. .Meanwhile, TSCL continues to work for passage of Notch Fairness Act, legislation that would provide ,000 payable in four annual installments, or an improved monthly benefit. The bill has been re-introduced in both the House and the Senate and has 22 co-sponsors. TSCL remains committed to Notch Reform and we continue to meet with Members of Congress to build support for this needed remedy. .Totalization Agreement with Mexico – Preventing an unnecessary and unspecified drain on the Social Security Trust Fund. .The rule would require drug companies to give Medicare beneficiaries rebates that now go to insurers and PBMs. The nonpartisan Congressional Budget Office estimates it would increase taxpayer costs by 7 billion over 10 years. .Allowing individuals to import prescription drugs from abroad. Many Medicare beneficiaries spend thousands of dollars every month on lifesaving medications under the Part D program. The bipartisan Safe and Affordable Drugs from Canada Act (S. 61) would allow these individuals import their prescription drugs from approved pharmacies in Canada, where medicines are often half the cost. This critical bill would improve access to affordable medication for older Americans, and it would bring down costs nationwide by increasing competition in the American marketplace. .The Preserve Access to Affordable Generics and Biosimilars Act (S. 64), also introduced by Senators Grassley and Klobuchar, would prohibit anti-competitive pay-for-delay deals that keep much cheaper generic and biosimilar medicines off the market.